Osteoporosis
InVivo Therapeutics planning a reverse merger . . . MiMedx to raise $5.0 million . . . FDA clears ArthroCare's Parallax device to treat VCFs . . . Osseon Therapeutics announces 1,000-patient milestone . . . AAOS releases clinical guidelines for vertebroplasty and kyphoplasty . . . ProChon reports BioCart Autologous Cartilage System outcomes . . . RepRegen releases in vivo StronBone data more
A new study in the British Medical Journal concluded that oral bisphosphonates, a class of osteoporosis drugs that includes Fosamax, Boniva and Zometa, may be associated with doubled risk of esophageal cancer. more
A year after two New England Journal of Medicine studies shook up perspectives on vertebroplasty, new data has been released showing the efficacy of the procedure and emphasizing some of the shortcomings of the NEJM papers. more
Medtronic announces FQ4 . . . Exactech acquires Brighton Partners, supplier of Optetrak knee material . . . VentureMD closes funding round . . . KFx cleared to market AppianFx knee products . . . X-spine receives FDA clearance for Fixcet Spinal Facet Screw System . . . Applied Spine awarded patents . . . DFine, Vertos release clinical data . . . curasan collaborates with Matricel on bone graft substitute . . . SpineGuard appoints Alan Olsen Chairman of the Board more
According to an article published this month in the journal Bone, researchers in Michigan have discovered that observing changes in collagen may give clues to bone health. Current methods of diagnosing conditions like osteoporosis rely primarily on the mineral density... more
An article in the New York Times this week discussed osteopenia, a controversial diagnosis made when bone density is lower than average but does not meet the clinical criteria for osteoporosis. Osteopenia was defined by the WHO in 1994, and... more
Complete Archive
